Johann S. de Bono
Royal Marsden NHS Foundation Trust(GB)Institute of Cancer Research(GB)Royal Marsden Hospital(GB)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, Cancer, Lipids, and Metabolism, Cancer Genomics and Diagnostics, PARP inhibition in cancer therapy
Most-Cited Works
- → Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy(2012)4,537 cited
- → Abiraterone and Increased Survival in Metastatic Prostate Cancer(2011)4,364 cited
- → Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers(2009)3,610 cited
- → Integrative Clinical Genomics of Advanced Prostate Cancer(2015)3,599 cited
- → Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial(2010)3,265 cited
- → Pan-cancer analysis of whole genomes(2020)3,205 cited